Indian Pharmaceuticals
- All
- News
- Videos
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
Pharma OTT Release: When, Where to Watch the Malayalam Medical Thriller Web Series
The series shows the conspiracy of unethical drug selling in which many high stake people are involved. It is a suspenseful story with lots of twists and turns and it stars with Nivin Pauly and other effective supporting roles.Pharma is an Indian techno-thriller that uncovers the shadowy world of medicine, morality and massive pharmaceutical power.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
Why Trump's 50% Tariffs May Not Hurt India's Growth, S&P Rating Explains
US President Donald Trump's punitive tariffs on Indian imports will not impact India's economic growth, and its sovereign ratings outlook will remain positive, according to S&P Global Ratings Director YeeFarn Phua.
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
Pharma OTT Release: When, Where to Watch the Malayalam Medical Thriller Web Series
The series shows the conspiracy of unethical drug selling in which many high stake people are involved. It is a suspenseful story with lots of twists and turns and it stars with Nivin Pauly and other effective supporting roles.Pharma is an Indian techno-thriller that uncovers the shadowy world of medicine, morality and massive pharmaceutical power.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
Why Trump's 50% Tariffs May Not Hurt India's Growth, S&P Rating Explains
US President Donald Trump's punitive tariffs on Indian imports will not impact India's economic growth, and its sovereign ratings outlook will remain positive, according to S&P Global Ratings Director YeeFarn Phua.
